Pharm Neuro Part 2A

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/157

encourage image

There's no tags or description

Looks like no tags are added yet.

158 Terms

1
New cards

Succinimides: drug (generic/trade)

Ethosuximide (Zarontin)

2
New cards

Ethosuximide (Zarontin) dose

PO; 250-500 mg daily; may increase to max 1.5 g/day

3
New cards

Succinimides: mechanism of action

Block T-type voltage-gated Ca2+ channels in thalamic neurons → raise seizure threshold

4
New cards

Succinimides: absorption

Oral; well absorbed from GI tract

5
New cards

Succinimides: distribution

Well distributed

6
New cards

Succinimides: metabolism

Liver

7
New cards

Succinimides: excretion

Urine

8
New cards

Succinimides: clinical use

Absence (petit mal) seizures in children and adults refractory to other drugs

9
New cards

Succinimides: derm adverse reactions

Rash; pruritus; SJS

10
New cards

Succinimides: GI adverse reactions

Nausea; abdominal pain; gingival hyperplasia

11
New cards

Succinimides: heme adverse reaction

Agranulocytosis

12
New cards

Succinimides: neuro adverse reactions

Depression; headache; mood changes; lethargy; ataxia

13
New cards

Succinimides: misc adverse reactions

Increased libido; hirsutism

14
New cards

Succinimides + TCAs, phenothiazines, antihistamines, or alcohol

Increased CNS depression

15
New cards

Succinimides + oral contraceptives

May reduce contraceptive effectiveness

16
New cards

Succinimides: contraindication

History of hypersensitivity

17
New cards

Succinimides: use cautiously in

Liver or kidney disease; blood dyscrasias

18
New cards

Succinimides: monitoring

Plasma levels; periodic liver, renal, and heme studies

19
New cards

Ethosuximide and breastfeeding

Crosses into breast milk

20
New cards

Succinimides: tip for GI distress

Take with a glass of milk

21
New cards

Succinimides: patient education - contraception

Use backup birth control if on oral contraceptives

22
New cards

Zonisamide (Zonegran): class

Sulfonamide derivative

23
New cards

Zonisamide (Zonegran) dose

PO; 100 mg/day x 2 wk; may increase to 200, then 400-600 mg/day at 2-week intervals

24
New cards

Gabapentin (Neurontin) dose

PO; 300 mg TID; may increase up to 1,800 mg/day

25
New cards

Tiagabine (Gabitril) dose

PO; 4 mg daily x 1 week; increase 4-8 mg/week by response

26
New cards

Valproate (Depakote) dose

PO; up to 2,500 mg/day in divided doses

27
New cards

Anticonvulsants with unknown mechanism

Lamotrigine; felbamate; clonazepam

28
New cards

Lamotrigine (Lamictal) dose

PO; 25 mg BID; increase weekly to max 200 mg BID

29
New cards

Felbamate (Felbatol) dose

PO; 100 mg/day in 3-4 divided doses

30
New cards

Clonazepam (Klonopin) dose

PO; 1.5 mg in 3 divided doses; increase 0.5-1 mg every 3 days until controlled

31
New cards

Pregabalin (Lyrica): route

PO

32
New cards

Levetiracetam (Keppra, Keppra SR) dose

PO or IV; 500 mg BID; increase every 2 weeks to max 3,000 mg/day

33
New cards

Topiramate (Topamax) dose: adults and children >10

PO; 400 mg/day in divided doses

34
New cards

Topiramate (Topamax) dose: age 2-10

Start 25 mg/day; titrate by weight

35
New cards

Lacosamide (Vimpat) dose

PO; 50 mg BID; increase weekly to 200-400 mg/day BID

36
New cards

Benzodiazepines used as anticonvulsants

Clonazepam (Klonopin); diazepam (Valium); lorazepam (Ativan)

37
New cards

Benzodiazepines: anticonvulsant mechanism

Enhance GABA; slow CNS activity; suppress absence-seizure discharge in motor cortex

38
New cards

Benzodiazepines given IV for status epilepticus

Diazepam; lorazepam

39
New cards

Rectal diazepam gel: use

Seizure clusters

40
New cards

GABA enhancers (generic/trade)

Gabapentin (Neurontin); tiagabine (Gabitril); valproate (Depakote); vigabatrin (Sabril)

41
New cards

GABA enhancers: main seizure use

Oral agents for refractory complex partial seizures in adults

42
New cards

Vigabatrin (Sabril): when used

After other options fail; loss of vision risk

43
New cards

Vigabatrin (Sabril): age restriction

Typically late teens or adults

44
New cards

Tiagabine (Gabitril): mechanism

Selective GABA reuptake inhibitor → more synaptic GABA

45
New cards

Tiagabine (Gabitril): main use

Adjunctive therapy for epilepsy (partial seizures)

46
New cards

Gabapentin: drug class

GABA analogue

47
New cards

Gabapentin: trade names and forms

Neurontin, Nupentin; tablets, capsules, oral solution

48
New cards

Gabapentin: uses

Restless leg syndrome; postherpetic neuralgia (PHN); seizures

49
New cards

Gabapentin: mechanism

Decreases excitatory nerve impulses in the brain

50
New cards

Valproic acid/valproate sodium: trade names

Depakote; Depacon; Depakene

51
New cards

Valproate: seizure uses

Complex partial and absence seizures

52
New cards

Valproate: weight effect

Significant weight gain

53
New cards

Valproate: high plasma level toxicity

Severe tremors; liver damage (fatal in children)

54
New cards

Valproate: how to reduce toxicity risk

Routine blood tests and careful monitoring

55
New cards

Valproate: mechanism

Blocks Na+ channels and T-type Ca2+ channels; inhibits GABA transaminase (↑GABA)

56
New cards

Why is valproate broad-spectrum?

It acts by several mechanisms (Na+, Ca2+, and GABA)

57
New cards

Valproate: non-seizure uses

Manic phase of bipolar disorder; migraine prophylaxis

58
New cards

Peripheral neuropathy: definition

Damage to the peripheral nervous system

59
New cards

Number of peripheral neuropathy types

More than 100

60
New cards

Peripheral neuropathy symptoms depend on

Type of nerve damaged: motor, sensory, or autonomic

61
New cards

Peripheral neuropathy: milder symptoms

Numbness; tingling; pricking; touch sensitivity; muscle weakness

62
New cards

Peripheral neuropathy: severe symptoms

Pain (especially at night); muscle wasting; paralysis; organ/gland dysfunction

63
New cards

Peripheral neuropathy: acquired causes

Trauma; tumors; toxins; autoimmune; nutritional deficiency; alcoholism; vascular/metabolic disorders

64
New cards

Peripheral neuropathy: inherited or acquired?

Either

65
New cards

Peripheral neuropathy: cure?

No cure; medications relieve pain

66
New cards

Neuropathy pain relievers

Mild: OTC acetaminophen or NSAIDs; severe: opioids

67
New cards

Anticonvulsants for neuropathy

Gabapentin; topiramate; pregabalin; carbamazepine; phenytoin

68
New cards

Anticonvulsants for neuropathy: drawbacks

Drowsiness; dizziness

69
New cards

Capsaicin cream

Warming agent from hot peppers; modest relief for foot neuropathy; warming sensation can be hard to tolerate

70
New cards

Lidocaine patch

Topical anesthetic; up to 4 patches/day; no side effects but may cause rash

71
New cards

TCAs for neuropathy

Amitriptyline (Elavil); nortriptyline (Aventyl, Pamelor)

72
New cards

TCAs for neuropathy: mechanism

Interfere with serotonin and norepinephrine → diminish pain

73
New cards

Duloxetine (Cymbalta) for neuropathy

SNRI; effective for diabetic peripheral neuropathy

74
New cards

TENS: full name

Transcutaneous electrical nerve stimulation

75
New cards

TENS: how it works

Skin electrodes deliver a gentle current to stimulate nerve transmission

76
New cards

TENS: requirements for effectiveness

Regular use; frequency below motor contraction or one that produces contraction

77
New cards

MS: significance

Most common cause of chronic neurological disability in young adults

78
New cards

MS: disability at 15 years

About half cannot walk without assistance

79
New cards

MS: can drugs halt disability?

No; disease-modifying drugs improve progression outcomes

80
New cards

MS: pathology

Myelin sheath develops plaques that disrupt nerve transmission; cause unknown

81
New cards

MS drugs: general mechanism

Suppress or alter immune system activity

82
New cards

MS exacerbation: other names

Relapse; attack; flare-up

83
New cards

MS exacerbation: definition

New symptoms or worsening of old symptoms

84
New cards

MS exacerbation: examples

Optic neuritis; impaired balance/walking (footdrop); severe fatigue

85
New cards

MS exacerbation: criteria

Lasts at least 24 hours; at least 30 days after the previous attack

86
New cards

MS exacerbation: typical duration

A few days to several weeks or months

87
New cards

Interferon beta-1a (Avonex, Rebif): use

Relapsing-remitting and secondary progressive MS

88
New cards

Interferon beta-1a (Avonex, Rebif): route and dosing

IM 30 mcg once/week OR SC 44 mcg 3 times/week

89
New cards

Interferon beta-1a/1b: common side effect

Mild flu-like symptoms

90
New cards

Interferon beta-1b (Betaseron, Betaferon, Extavia): use

Relapsing-remitting and secondary progressive MS

91
New cards

Interferon beta-1b: route and dosing

SC 30 mcg every 2 days

92
New cards

Glatiramer acetate (Copaxone)

Relapsing-remitting MS; 20 mg SC daily; side effect: injection site reaction

93
New cards

Mitoxantrone (Novantrone): use

Rapidly worsening relapsing-remitting and progressive-relapsing MS

94
New cards

Mitoxantrone (Novantrone): dosing

IV 12 mg/m2 every 3 months (4 times/year)

95
New cards

Mitoxantrone (Novantrone): side effects

Nausea; thinning hair; decreased WBC

96
New cards

Natalizumab (Tysabri)

Relapsing MS; 300 mg IV over 1 hr every 4 weeks

97
New cards

Natalizumab (Tysabri): side effects

Headache; lethargy; joint pain

98
New cards

Fingolimod (Gilenya)

Relapsing-remitting MS; 0.5 mg PO daily

99
New cards

Fingolimod (Gilenya): side effects

Eye toxicity; increased infection risk

100
New cards

Only oral MS drug on the table

Fingolimod (Gilenya)